Arq-e-Ajwain in the management of Anaemia.

Therapeutic Evaluation of Arq-e-Ajwain in Iron Deficiency Anaemia in Reproductive Age Women: A Randomized Control Trial.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012583

Enrollment

Registered

2018-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- iron deficiency anaemia in reproductive age women

Interventions

Intervention1: arq-e-ajwain: Ajwain (Trichyspermum ammi L) 1.0 kg Aab (purified water) 12.0 l Control Intervention1: qurs kusta faulad: Unani Formulation

Eligibility

Inclusion criteria

Inclusion criteria: Female patients in the age group of 18-40 years. Hb (8-11g %).

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. History of systemic illness, endocrinal disease and malignancy. Surgical h/o gastrectomy, gastrojejunostomy. H/o Haemoglobinopathies

Design outcomes

Primary

Measure	Time frame
Hb%Timepoint: 0th day, 15th day, 30th day follow up	—

Secondary

Measure	Time frame
Change in subjective parameters.Timepoint: 0th day, 15th day, 30th day follow up	—

Countries

India

Contacts

Public ContactDr Mariyam Roqaiya

Luqman Unani Medical College, Hospital and Research center

dr.mroqaiya@gmail.com9632560839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026